These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 35107451)

  • 21. Macrolactin A as a Novel Inhibitory Agent for SARS-CoV-2 M
    Bharadwaj KK; Sarkar T; Ghosh A; Baishya D; Rabha B; Panda MK; Nelson BR; John AB; Sheikh HI; Dash BP; Edinur HA; Pati S
    Appl Biochem Biotechnol; 2021 Oct; 193(10):3371-3394. PubMed ID: 34212286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe acute respiratory syndrome coronavirus 3C-like proteinase N terminus is indispensable for proteolytic activity but not for enzyme dimerization. Biochemical and thermodynamic investigation in conjunction with molecular dynamics simulations.
    Chen S; Chen L; Tan J; Chen J; Du L; Sun T; Shen J; Chen K; Jiang H; Shen X
    J Biol Chem; 2005 Jan; 280(1):164-73. PubMed ID: 15507456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study.
    Wang J
    J Chem Inf Model; 2020 Jun; 60(6):3277-3286. PubMed ID: 32315171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition mechanism and hot-spot prediction of nine potential drugs for SARS-CoV-2 M
    Luo S; Huang K; Zhao X; Cong Y; Zhang JZH; Duan L
    Nanoscale; 2021 May; 13(17):8313-8332. PubMed ID: 33900318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Silico Characterization of Masitinib Interaction with SARS-CoV-2 Main Protease.
    Martínez-Ortega U; Figueroa-Figueroa DI; Hernández-Luis F; Aguayo-Ortiz R
    ChemMedChem; 2021 Aug; 16(15):2339-2344. PubMed ID: 34142459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-throughput design of symmetrical dimeric SARS-CoV-2 main protease: structural and physical insights into hotspots for adaptation and therapeutics.
    Padhi AK; Tripathi T
    Phys Chem Chem Phys; 2022 Apr; 24(16):9141-9145. PubMed ID: 35411366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular docking and simulation studies on SARS-CoV-2 M
    Lokhande KB; Doiphode S; Vyas R; Swamy KV
    J Biomol Struct Dyn; 2021 Nov; 39(18):7294-7305. PubMed ID: 32815481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of potential inhibitors of the dimeric SARS-CoV2 main proteinase through the MM/GBSA approach.
    Bello M
    J Mol Graph Model; 2020 Dec; 101():107762. PubMed ID: 33022569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms.
    Nutho B; Mahalapbutr P; Hengphasatporn K; Pattaranggoon NC; Simanon N; Shigeta Y; Hannongbua S; Rungrotmongkol T
    Biochemistry; 2020 May; 59(18):1769-1779. PubMed ID: 32293875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease.
    Chiou WC; Chen JC; Chen YT; Yang JM; Hwang LH; Lyu YS; Yang HY; Huang C
    Biochem Biophys Res Commun; 2022 Feb; 591():130-136. PubMed ID: 33454058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elucidating biophysical basis of binding of inhibitors to SARS-CoV-2 main protease by using molecular dynamics simulations and free energy calculations.
    Sk MF; Roy R; Jonniya NA; Poddar S; Kar P
    J Biomol Struct Dyn; 2021 Jul; 39(10):3649-3661. PubMed ID: 32396767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Inhibition of SARS-CoV-2 3CL M
    Wang J; Yu Y; Leng T; Li Y; Lee ST
    ACS Appl Mater Interfaces; 2022 Jan; 14(1):191-200. PubMed ID: 34933561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease.
    Kumar N; Sood D; van der Spek PJ; Sharma HS; Chandra R
    J Proteome Res; 2020 Nov; 19(11):4678-4689. PubMed ID: 32786685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silybin B and Cianidanol Inhibit M
    Srivastava R; Tripathi S; Unni S; Hussain A; Haque S; Dasgupta N; Singh V; Mishra BN
    Curr Pharm Des; 2021; 27(32):3476-3489. PubMed ID: 33302853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Without its N-finger, the main protease of severe acute respiratory syndrome coronavirus can form a novel dimer through its C-terminal domain.
    Zhong N; Zhang S; Zou P; Chen J; Kang X; Li Z; Liang C; Jin C; Xia B
    J Virol; 2008 May; 82(9):4227-34. PubMed ID: 18305043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential of NO donor furoxan as SARS-CoV-2 main protease (M
    Al-Sehemi AG; Pannipara M; Parulekar RS; Patil O; Choudhari PB; Bhatia MS; Zubaidha PK; Tamboli Y
    J Biomol Struct Dyn; 2021 Sep; 39(15):5804-5818. PubMed ID: 32643550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanistic Insights into SARS-CoV-2 Main Protease Inhibition Reveals Hotspot Residues.
    Marimuthu P; Gorle S; Karnati KR
    J Chem Inf Model; 2021 Dec; 61(12):6053-6065. PubMed ID: 34842417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. pH-dependent conformational flexibility of the SARS-CoV main proteinase (M(pro)) dimer: molecular dynamics simulations and multiple X-ray structure analyses.
    Tan J; Verschueren KH; Anand K; Shen J; Yang M; Xu Y; Rao Z; Bigalke J; Heisen B; Mesters JR; Chen K; Shen X; Jiang H; Hilgenfeld R
    J Mol Biol; 2005 Nov; 354(1):25-40. PubMed ID: 16242152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Covalent and non-covalent binding free energy calculations for peptidomimetic inhibitors of SARS-CoV-2 main protease.
    Awoonor-Williams E; Abu-Saleh AAA
    Phys Chem Chem Phys; 2021 Mar; 23(11):6746-6757. PubMed ID: 33711090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.